BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dy GK, Hobday TJ, Nelson G, Windschitl HE, O’Connell MJ, Alberts SR, Goldberg RM, Nikcevich DA, Sargent DJ. Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: a North Central Cancer Treatment Group review of 3811 patients, N0144. Clin Colorectal Cancer. 2009;8:88-93. [PMID: 19739269 DOI: 10.3816/ccc.2009.n.014] [Cited by in Crossref: 45] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Tang YA, Chen YF, Bao Y, Mahara S, Yatim SMJM, Oguz G, Lee PL, Feng M, Cai Y, Tan EY, Fong SS, Yang ZH, Lan P, Wu XJ, Yu Q. Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer. Proc Natl Acad Sci U S A 2018;115:E5990-9. [PMID: 29891662 DOI: 10.1073/pnas.1801348115] [Cited by in Crossref: 77] [Cited by in F6Publishing: 81] [Article Influence: 25.7] [Reference Citation Analysis]
2 Long Y, Wang D. Inhibition of Colon Cancer Cell Growth by Imidazole Through Activation of Apoptotic Pathway. Med Sci Monit 2019;25:7597-604. [PMID: 31597910 DOI: 10.12659/MSM.917779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Downs-Canner S, Shuai Y, Ramalingam L, Pingpank JF, Holtzman MP, Zeh HJ, Bartlett DL, Choudry HA. Safety and efficacy of combined resection of colorectal peritoneal and liver metastases. J Surg Res 2017;219:194-201. [PMID: 29078882 DOI: 10.1016/j.jss.2017.05.126] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
4 Deng X, Kong F, Li S, Jiang H, Dong L, Xu X, Zhang X, Yuan H, Xu Y, Chu Y, Peng H, Guan M. A KLF4/PiHL/EZH2/HMGA2 regulatory axis and its function in promoting oxaliplatin-resistance of colorectal cancer. Cell Death Dis 2021;12:485. [PMID: 33986248 DOI: 10.1038/s41419-021-03753-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Cohen JD, Javed AA, Thoburn C, Wong F, Tie J, Gibbs P, Schmidt CM, Yip-Schneider MT, Allen PJ, Schattner M. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers. Proc Natl Acad Sci USA. 2017;114:10202-10207. [PMID: 28874546 DOI: 10.1073/pnas.1704961114] [Cited by in Crossref: 256] [Cited by in F6Publishing: 231] [Article Influence: 64.0] [Reference Citation Analysis]
6 Bose D, Zimmerman LJ, Pierobon M, Petricoin E, Tozzi F, Parikh A, Fan F, Dallas N, Xia L, Gaur P, Samuel S, Liebler DC, Ellis LM. Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells. Br J Cancer 2011;105:1759-67. [PMID: 22045189 DOI: 10.1038/bjc.2011.449] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.4] [Reference Citation Analysis]
7 Zhang L, Li L, Wang Y, Liu Y, Li C. MC3 Mucoepidermoid carcinoma cell line enriched cancer stem-like cells following chemotherapy. Oncol Lett 2014;7:1569-75. [PMID: 24765178 DOI: 10.3892/ol.2014.1902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
8 Zhang Y, Hu X, Miao X, Zhu K, Cui S, Meng Q, Sun J, Wang T. MicroRNA-425-5p regulates chemoresistance in colorectal cancer cells via regulation of Programmed Cell Death 10. J Cell Mol Med 2016;20:360-9. [PMID: 26647742 DOI: 10.1111/jcmm.12742] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 8.8] [Reference Citation Analysis]
9 Paul D, Gold M, Nouraddin N. Prolonged survival in metastatic colorectal cancer following chemotherapy. Clin Case Rep 2014;2:219-23. [PMID: 25614815 DOI: 10.1002/ccr3.109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 de Jong MC, van Dam RM, Maas M, Bemelmans MH, Olde Damink SW, Beets GL, Dejong CH. The liver-first approach for synchronous colorectal liver metastasis: a 5-year single-centre experience. HPB (Oxford). 2011;13:745-752. [PMID: 21929676 DOI: 10.1111/j.1477-2574.2011.00372.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
11 Lucidi V, Hendlisz A, Van Laethem JL, Donckier V. Missing metastases as a model to challenge current therapeutic algorithms in colorectal liver metastases. World J Gastroenterol 2016; 22(15): 3937-3944 [PMID: 27099436 DOI: 10.3748/wjg.v22.i15.3937] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
12 Delgado-Ureña M, Ortega FG, de Miguel-Pérez D, Rodriguez-Martínez A, García-Puche JL, Ilyine H, Lorente JA, Exposito-Hernandez J, Garrido-Navas MC, Delgado-Ramirez M, Serrano MJ. Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients. J Transl Med 2018;16:251. [PMID: 30189880 DOI: 10.1186/s12967-018-1624-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
13 Blackham AU, Swett K, Levine EA, Shen P. Surgical management of colorectal cancer metastases to the liver: multimodality approach and a single institutional experience. Colorectal Cancer 2013;2:73-88. [PMID: 25110522 DOI: 10.2217/crc.12.80] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
14 Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, Pitot HC, Grothey A, Alberts SR, Sargent DJ. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30:263-267. [PMID: 22162570 DOI: 10.1200/jco.2011.37.1039] [Cited by in Crossref: 333] [Cited by in F6Publishing: 122] [Article Influence: 33.3] [Reference Citation Analysis]
15 Raoof M, Jutric Z, Haye S, Ituarte PHG, Zhao B, Singh G, Melstrom L, Warner SG, Clary B, Fong Y. Systematic failure to operate on colorectal cancer liver metastases in California. Cancer Med 2020;9:6256-67. [PMID: 32687265 DOI: 10.1002/cam4.3316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Kim E, Bay GH, Kim CA. Durable complete response in a patient with metastatic left-sided colon cancer treated with 5-fluorouracil, folinic acid, and irinotecan (FOLFIRI) and panitumumab: A case report. Clin Case Rep 2019;7:1302-5. [PMID: 31360471 DOI: 10.1002/ccr3.2210] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Wu C, Liu X, Li B, Sun G, Peng C, Xiang D. miR‑451 suppresses the malignant characteristics of colorectal cancer via targeting SAMD4B. Mol Med Rep 2021;24:557. [PMID: 34109425 DOI: 10.3892/mmr.2021.12196] [Reference Citation Analysis]